Seres Therapeutics, Inc. (90) | Business Operations (8)
Browse by Subcategory
Recent Contracts
-
Supply Agreement, dated September 15, 2015, by and between Seres Therapeutics, Inc. and GenIbet BioPharmaceuticals, SA, as amended
(Filed With SEC on November 2, 2022)
-
Placement Agency Agreement, dated June 29, 2022, by and between Seres Therapeutics, Inc. and J.P. Morgan Securities LLC
(Filed With SEC on June 30, 2022)
-
Sales Agreement, dated as of May 21, 2021, between Seres Therapeutics, Inc. and Cowen and Company, LLC
(Filed With SEC on May 21, 2021)
-
Advisory Agreement, dated December 12, 2019, by and between the Registrant and Roger Pomerantz
(Filed With SEC on March 2, 2020)
-
Research Collaboration and Option Agreement, dated March 11, 2019, by and between the Registrant and MedImmune, LLC
(Filed With SEC on May 2, 2019)
-
Sales Agreement, dated as of March 18, 2020, between Seres Therapeutics, Inc. and Cowen and Company, LLC
(Filed With SEC on March 18, 2020)
-
Sales Agreement, dated as of November 27, 2019, between Seres Therapeutics, Inc. and Cowen and Company, LLC
(Filed With SEC on November 27, 2019)
-
Amendment No 1 to the Collaboration and License Agreement, dated August 10, 2016, by and between the Registrant and Nestec Ltd
(Filed With SEC on March 6, 2019)